Location History:
- Shanghai, CN (2013)
- Xixia District, CN (2013)
Company Filing History:
Years Active: 2013
Title: Xufeng Cao: Innovator in Pharmaceutical Chemistry
Introduction
Xufeng Cao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of new crystalline forms of agomelatine. With a total of 2 patents, his work has the potential to enhance the efficacy and stability of pharmaceutical formulations.
Latest Patents
Cao's latest patents include "Crystalline form VI of agomelatine, preparation method and application thereof." This invention presents a new crystalline form of agomelatine characterized by high purity, stability, and good reproducibility. The X-ray powder diffraction diagram of this crystalline form reveals main peaks at specific diffraction angles, indicating its unique properties. Additionally, the stability and solubility of this new form surpass those of several existing crystalline forms, making it advantageous for pharmaceutical applications.
Another notable patent is "Agomelatine hydrohalide complex and preparation method thereof." This invention relates to a complex of agomelatine that exhibits greater solubility, stability, and purity compared to agomelatine itself. The method described allows for the production of high-purity products through a straightforward process, eliminating the need for complicated steps.
Career Highlights
Throughout his career, Xufeng Cao has worked with reputable companies, including Les Laboratories Servier. His expertise in pharmaceutical chemistry has allowed him to contribute to the development of innovative solutions in the industry.
Collaborations
Cao has collaborated with notable colleagues such as Hanbin Shan and Zhedong Yuan. These partnerships have further enriched his research and development efforts in the field.
Conclusion
Xufeng Cao's contributions to pharmaceutical chemistry, particularly through his innovative patents, highlight his role as a key inventor in the industry. His work not only advances the understanding of agomelatine but also paves the way for improved pharmaceutical formulations.